Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,993 | -23,677 | -9,310 | -20,588 | -11,809 |
| Depreciation Amortization | -1,047 | -685 | -76 | -80 | 8 |
| Accounts payable and accrued liabilities | 2,611 | 3,223 | 648 | N/A | -395 |
| Other Working Capital | 1,029 | 2,028 | -2,357 | 1,573 | 758 |
| Other Operating Activity | 38 | -2,121 | -293 | 1,008 | 1,078 |
| Operating Cash Flow | $-37,362 | $-21,232 | $-11,388 | $-18,087 | $-10,360 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -124,651 | -124,651 | -124,651 | N/A | N/A |
| PPE Investments | -95 | -91 | N/A | -109 | -103 |
| Sale Of Investment | 50,777 | 21,527 | 12,027 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -11,889 | 0 |
| Investing Cash Flow | $-73,969 | $-103,215 | $-112,624 | $-11,998 | $-103 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 91,362 | 91,191 | 91,185 | N/A | 169 |
| Other Financing Activity | -2,387 | -2,387 | -2,310 | 81,991 | 82,836 |
| Financing Cash Flow | $88,975 | $88,804 | $88,875 | $81,991 | $83,005 |
| Beginning Cash Position | 61,641 | 61,641 | 61,641 | 9,735 | 9,735 |
| End Cash Position | 39,285 | 25,998 | 26,504 | 61,641 | 82,277 |
| Net Cash Flow | $-22,356 | $-35,643 | $-35,137 | $51,906 | $72,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,362 | -21,232 | -11,388 | -18,087 | -10,360 |
| Capital Expenditure | -95 | -91 | N/A | N/A | -103 |
| Free Cash Flow | -37,457 | -21,323 | -11,388 | -18,087 | -10,463 |